Duration of anticoagulant therapy after a first episode of an unprovoked pulmonary embolus or deep vein thrombosis: guidance from the SSC of the ISTH.
about
Recurrent venous thromboembolism: what is the risk and how to prevent itDuration of anticoagulation for venous thromboembolic eventsUnusual venous thrombosis in a 35-year-old man.Duration of anticoagulant therapy for venous thromboembolism: balancing benefits and harms on the long term.Treatment options for venous thromboembolism: lessons learnt from clinical trials.Recurrent venous thromboembolism and abnormal uterine bleeding with anticoagulant and hormone therapy usePopulation-specific single-nucleotide polymorphism confers increased risk of venous thromboembolism in African Americans.Testing for thrombophilia: clinical update.Upper extremity deep vein thrombosis in a military patient.Clinical course of isolated distal deep vein thrombosis in patients with active cancer: a multicenter cohort study.Recurrence risk of venous thromboembolism and hormone use in women from England: a cohort study using clinical practice research datalink.The 2016 American College of Chest Physicians treatment guidelines for venous thromboembolism: a review and critical appraisal.Use of factor concentrates for the management of perioperative bleeding: guidance from the SSC of the ISTH.The identification of at-risk patients and prevention of venous thromboembolism in pediatric cancer: guidance from the SSC of the ISTH.Deep vein thrombosis in a transgender woman.How long to anticoagulate?Antithrombotic therapy for venous thromboembolism in myeloproliferative neoplasms.
P2860
Q26826847-2BF28106-C06D-4D32-B319-FAAE316AB896Q28081375-8A10C7CF-1A6D-4784-9EDD-734365620812Q30562555-D94453E5-4A13-40DA-B879-2D5C0BE13BE7Q34284224-AB761F33-4B56-4A4D-8B59-89AFEBF1CE62Q34694544-27B3C45D-4D58-41EE-BB94-9901926865E2Q36800361-03B6AF44-6AF4-41BD-B17F-3F1F3A8F76EFQ37257102-32B6F99F-1DF8-4BCC-9398-A8CF70044AA4Q37527119-A495EBB7-FA4A-4A0C-975B-ED0471A132DCQ38516851-68FCF940-4C00-42C6-8CAD-56A539CC2D4DQ38714436-78B41C3F-822A-43B1-B445-B8079C584999Q38851530-F3545ABC-903A-4657-A484-D62721071287Q38987037-1C1BFF52-12F4-4344-A5BE-6BD25413AB83Q47228028-D9428720-C58A-43FC-92BC-568E55479092Q49602494-FDEF5C26-83AD-4E5C-B741-A28676A2D7FDQ50927397-B102B8F4-C743-4F63-82A3-7D6869ED52FBQ51094443-55FD6B18-83CA-4177-AAA0-F967D9E4A015Q55286559-80E0782B-88D2-4FC1-BB3A-505341A98D4A
P2860
Duration of anticoagulant therapy after a first episode of an unprovoked pulmonary embolus or deep vein thrombosis: guidance from the SSC of the ISTH.
description
2012 nî lūn-bûn
@nan
2012 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Duration of anticoagulant ther ...... ance from the SSC of the ISTH.
@ast
Duration of anticoagulant ther ...... ance from the SSC of the ISTH.
@en
Duration of anticoagulant ther ...... ance from the SSC of the ISTH.
@nl
type
label
Duration of anticoagulant ther ...... ance from the SSC of the ISTH.
@ast
Duration of anticoagulant ther ...... ance from the SSC of the ISTH.
@en
Duration of anticoagulant ther ...... ance from the SSC of the ISTH.
@nl
prefLabel
Duration of anticoagulant ther ...... ance from the SSC of the ISTH.
@ast
Duration of anticoagulant ther ...... ance from the SSC of the ISTH.
@en
Duration of anticoagulant ther ...... ance from the SSC of the ISTH.
@nl
P2093
P2860
P1476
Duration of anticoagulant ther ...... ance from the SSC of the ISTH.
@en
P2093
A Srivastava
J Douketis
SSC of the ISTH
P2860
P304
P356
10.1111/J.1538-7836.2012.04662.X
P577
2012-04-01T00:00:00Z